To read the full story, subscribe or sign in.

MRX-4 improves several symptoms of grass pollen allergy

June 14, 2010

No Comments

BioWorld Science Conferences Respiratory

Today's news in brief

BioWorld

BioWorld briefs for Dec. 5, 2023.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 5, 2023.

Aurinia Therapeutics’ AUR-300 proven useful in systemic sclerosis

BioWorld Science

Aurinia Pharmaceuticals Inc. has investigated their CD206 ligand AUR-300 as a novel therapeutic agent for systemic sclerosis treatment.

‘Ridiculous’ site-based hitches mar Biovie phase III in Alzheimer’s

BioWorld

For the second time this week, a contract research organization has come under fire for trial-conduct issues – criticism leveled most recently by Biovie Inc.,...

Waging the losing battle: Altimmune takes on challengers as Pfizer falls back

BioWorld

Altimmune Inc.’s peptide-based glucagon-like peptide-1/glucagon dual receptor agonist pemvidutide hiccupped in a phase I study earlier this year but has bounced...

Upgrade your daily dose of biopharma and medtech news

MRX-4 improves several symptoms of grass pollen allergy